ALLR

Allarity Therapeutics
$1.23
+$0.04 (+3.36%)Jul 27, 2026
1.2PoorMoatMint rating

MoatMint rates Allarity Therapeutics (ALLR) 1.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.0 out of 10.

Key metrics

The numbers that frame ALLR today
Market cap
$19.57M
P/E (TTM)
-1.7
EV / FCF
-0.7
Gross margin
100%
EV / Sales
32.6
ROIC
345.6%
Div yield
0%
Debt / equity
3.1
52wk Low
$0.77
52wk High
$2.35

ALLR stock rating

How ALLR scores on quality, value, growth, momentum and financial health
1.2out of 10
Low overallNeutral business, expensive priceTop 88% of ~5,000 US stocks
QualityPoor1.0/10
GrowthFair3.3/10
MomentumNeutral5.5/10
ValuePoor0.3/10
Financial HealthFair2.1/10

Growth

Revenue and earnings trend for ALLR
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ALLR
Is Allarity Therapeutics a good buy?
No. Allarity Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks weak. That could put pressure on the long-term business case. We think Allarity Therapeutics is selling at a very high price.
What is the market capitalization of ALLR?
Allarity Therapeutics's market capitalization is $19.57M.
What is the P/E ratio for ALLR stock?
Allarity Therapeutics's current P/E ratio is -1.7.
What is the 52-week high for ALLR stock?
The 52-week high for Allarity Therapeutics is $2.35. The current close of $1.23 is 47.7% below that high.
What is the 52-week low for ALLR stock?
The 52-week low for Allarity Therapeutics is $0.77. The current close of $1.23 is 59.9% above that low.
Does ALLR stock pay dividends?
Allarity Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALLR?
Allarity Therapeutics's Debt / Equity ratio is 3.11.